SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
HTLD

Heartland Express Inc (HTLD)

NASDAQ: HTLD · Real-Time Price · USD
Industrials · Trucking
10.06-0.12 (-1.18%)
 
Market cap
$778M
Health Score
Analyst consensus
Insider Score
––Not scored
HTLD Insider Score

Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

HTLD analyst forecast

HTLD analyst consensus

Hold4 ratings
Buy 0 Hold 2 Sell 2

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

HTLD 12-month price target

No published price targets in the last 12 months.

Best analysts covering HTLD

  • Barclays67%success rate · 9 calls
  • JP Morgan33%success rate · 3 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

HTLD analyst ratings

FirmPrice targetAction
—UBSNeutral——Reiterated2026-10-21
—BairdNeutral——Downgraded2026-10-20
—BarclaysUnderweight——Reiterated2026-08-13
—UBSNeutral——Reiterated2026-08-06
—JP MorganUnderweight——Reiterated2026-07-31
—Morgan StanleyEqual Weight——Reiterated2026-07-06
—BarclaysUnderweight——Reiterated2026-06-26
—BarclaysUnderweight——Reiterated2026-04-28
—JP MorganUnderweight——Reiterated2026-04-24
—BairdOutperform——Reiterated2026-04-24
—UBSNeutral——Reiterated2026-04-24
—BarclaysUnderweight——Reiterated2026-03-03
—UBSNeutral——Reiterated2026-02-05
—BarclaysUnderweight——Reiterated2026-01-15
—BairdOutperform——Upgraded2026-01-05
—Morgan StanleyEqual Weight——Reiterated2025-12-08
—BairdNeutral——Reiterated2025-11-03
—JP MorganUnderweight——Reiterated2025-10-08
—Morgan StanleyEqual Weight——Reiterated2025-10-06
—BarclaysUnderweight——Reiterated2025-08-06
—Morgan StanleyEqual Weight——Reiterated2025-08-04
—BairdNeutral——Reiterated2025-07-28
—JP MorganUnderweight——Reiterated2025-05-01
—BarclaysUnderweight——Reiterated2025-04-02
—BarclaysUnderweight——Reiterated2024-11-13
—BarclaysUnderweight——Reiterated2024-11-04
—UBSNeutral——Reiterated2024-10-30
—BarclaysUnderweight——Reiterated2024-08-01
—JP MorganUnderweight——Downgraded2024-07-09
—UBSNeutral——Downgraded2024-07-09
—BarclaysUnderweight——Reiterated2024-04-30
—JP MorganNeutral——Reiterated2024-04-24
—JP MorganNeutral——Reiterated2024-04-09
—BarclaysUnderweight——Reiterated2024-04-01
—Morgan StanleyEqual Weight——Reiterated2024-02-12
—JP MorganNeutral——Reiterated2023-12-21
—Morgan StanleyEqual Weight——Reiterated2023-10-02
—Morgan StanleyEqual Weight——Reiterated2023-08-07
—Stephens & Co.Equal Weight——Reiterated2023-08-01
—Morgan StanleyEqual Weight——Reiterated2023-07-06
—Stephens & Co.Equal Weight——Reiterated2023-05-01
—BarclaysUnderweight——Reiterated2023-01-11
—Morgan StanleyEqual Weight——Reiterated2023-01-11
—UBSBuy——Upgraded2022-11-11
—Morgan StanleyEqual Weight——Reiterated2022-08-29
—BairdNeutral——Reiterated2022-08-23
—JP MorganNeutral——Reiterated2022-04-08
—Morgan StanleyEqual Weight——Upgraded2022-03-15
—JP MorganNeutral——Downgraded2022-02-18
—BarclaysUnderweight——Downgraded2022-01-26
—BarclaysEqual Weight——Reiterated2022-01-14
—Morgan StanleyUnderweight——Reiterated2021-12-02
—JP MorganOverweight——Upgraded2021-07-01
—BairdNeutral——Downgraded2021-05-11
—KeybancSector Weight——Downgraded2021-02-01
—KeyBancSector Weight——Downgraded2021-02-01
—KeyBancSector Weight——Downgraded2021-01-31
—StifelBuy——Upgraded2021-01-21
—KeybancOverweight——Reiterated2020-10-19
—KeyBancOverweight——Reiterated2020-10-19

HTLD earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-04-23-0.13-0.06$175.2M$176.3M
2026-07-30-0.000.14$185.1M$184.1M
2026-10-200.030.01$181.4M$179.5M
2027-02-020.020.00$176.9M$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.